Literature DB >> 25071120

Evidence-based therapy for recurrent cervical cancer.

Bradley J Monk1, Krishnansu S Tewari2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25071120     DOI： 10.1200/JCO.2014.56.8733

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

1.  Prevention of a sexually transmitted disease versus prevention of a serious female cancer: remarkably divergent views of HPV vaccination.

Authors:  Maurie Markman
Journal:  Womens Health (Lond)       Date:  2016-01-12

2.  The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience.

Authors:  Seiji Mabuchi; Yuri Matsumoto; Naoko Komura; Masaaki Sawada; Mie Tanaka; Eriko Yokoi; Katsumi Kozasa; Akihiko Yoshimura; Hiromasa Kuroda; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2017-05-27       Impact factor: 3.402

Review 3.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

4.  Efficacy of local salvage therapy for recurrent uterine cervical cancer after definitive radiotherapy.

Authors:  Shinya Hiraoka; Aya Nakajima; Noriko Kishi; Keiichi Takehana; Hideki Hanazawa; Yukinori Matsuo; Takashi Mizowaki
Journal:  Int J Clin Oncol       Date:  2021-06-24       Impact factor: 3.402

5.  Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.

Authors:  Yunhai Chuai; Ivana Rizzuto; Xia Zhang; Ying Li; Guanghai Dai; Sophie J Otter; Rasiah Bharathan; Alexandra Stewart; Aiming Wang
Journal:  Cochrane Database Syst Rev       Date:  2021-03-04

6.  Hyperprogressive Disease In Cervical Small Cell Carcinoma Treated By Immune Checkpoint Inhibitor.

Authors:  Zihan Xu; Liying Chen; Linpeng Zheng; Qiao Yang; Mingjing Chen; Jianmin Wang; Guangkuo Zhu; Zhengtang Chen; Jianguo Sun
Journal:  Onco Targets Ther       Date:  2019-10-30       Impact factor: 4.147

7.  Selection of Treatment Regimens for Recurrent Cervical Cancer.

Authors:  Xiaopei Chao; Xiaochen Song; Huanwen Wu; Yan You; Ming Wu; Lei Li
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

8.  Bone recurrence after radical hysterectomy and lymphadenectomy in early-stage cervical cancer.

Authors:  Caner Çakır; Dilek Yüksel; Çiğdem Kılıç; Mehmet Ünsal; Rıza Dur; Gökhan Boyraz; Alper Karalok; Özlem Moraloğlu Tekin; Taner Turan
Journal:  Turk J Obstet Gynecol       Date:  2020-02-28

Review 9.  Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.

Authors:  Maryam Dadar; Sandip Chakraborty; Kuldeep Dhama; Minakshi Prasad; Rekha Khandia; Sameer Hassan; Ashok Munjal; Ruchi Tiwari; Kumaragurubaran Karthik; Deepak Kumar; Hafiz M N Iqbal; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-11-12       Impact factor: 7.561

10.  The Preliminary Results of 3-Dimensional Printed Individual Template Assisted 192Ir High-Dose Rate Interstitial Brachytherapy for Central Recurrent Gynecologic Cancer.

Authors:  Ping Jiang; Ang Qu; Shuhua Wei; Haitao Sun; Xile Zhang; Xu Li; Junjie Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.